Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Prime Medicine's annualizedGross Profit for the quarter that ended in Mar. 2024 was $2.36 Mil.
Prime Medicine's average Total Assets over the quarter that ended in Mar. 2024 was $252.62 Mil. Therefore, Prime Medicine's annualized Gross-Profit-to-Asset % for the quarter that ended in Mar. 2024 was 0.94%.
Prime Medicine Gross-Profit-to-Asset % Historical Data
The historical data trend for Prime Medicine's Gross-Profit-to-Asset % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Prime Medicine's Gross-Profit-to-Asset %
For the Biotechnology subindustry, Prime Medicine's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Prime Medicine's Gross-Profit-to-Asset % Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Prime Medicine's Gross-Profit-to-Asset % distribution charts can be found below:
* The bar in red indicates where Prime Medicine's Gross-Profit-to-Asset % falls into.
Prime Medicine Gross-Profit-to-Asset % Calculation
Prime Medicine's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Dec. 2023 is calculated as:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data,
the Gross Profit data used here is four times the quarterly (Mar. 2024) data.
Gross-Profit-to-Asset % is displayed in the 30-year financial page.
Prime Medicine Gross-Profit-to-Asset % Related Terms
Thank you for viewing the detailed overview of Prime Medicine's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.
Prime Medicine (Prime Medicine) Business Description
Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
PRME has been successfully added to your 